Fabiana J. Lubieniecki
1881 Combate De Los Pozos Street
B, Argentina
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Clinical, Histological, and Genetic Characterization of a Large Cohort of 49 Patients With Nebulin-Related Congenital Myopathy.
Journal: Human mutation
Published: January 25, 2026
In Vitro Stability and Preclinical Safety Evaluation of High-Dose Intravitreal Topotecan in Rabbits: Impact of Dose and Concentration.
Journal: Ophthalmology science
Published: July 01, 2025
PLAG1 fusions define a third subtype of CNS embryonal tumor with PLAG family gene alteration.
Journal: Acta neuropathologica
Published: May 08, 2025
A novel deep intronic variant in the DMD gene causes Duchenne muscular dystrophy by pseudoexon activation encoding a nonsense codon.
Journal: Gene
Published: May 13, 2024
Establishment and Comprehensive Characterization of a Novel Preclinical Platform of Metastatic Retinoblastoma for Therapeutic Developments.
Journal: Investigative ophthalmology & visual science
Published: December 20, 2023
Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma.
Journal: Pediatric blood & cancer
Published: July 28, 2023
Closing the gap: National Argentinian discussion forum on paediatric brain tumours.
Journal: Frontiers in oncology
Published: March 13, 2023
Severe ACTA1-related nemaline myopathy: intranuclear rods, cytoplasmic bodies, and enlarged perinuclear space as characteristic pathological features on muscle biopsies.
Journal: Acta neuropathologica communications
Published: June 17, 2022
The spectrum of morphological findings in pediatric central nervous system MN1-fusion-positive neuroepithelial tumors.
Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
Published: January 26, 2022
Medulloblastoma and Down Syndrome: An Extremely Rare Association.
Journal: Journal of pediatric hematology/oncology
Published: December 14, 2021
Targeted therapies with BRAF inhibitors for pediatric low- and high-grade gliomas with BRAFv600e mutation. Prof. Dr. Juan P. Garrahan Hospital experience
Journal: Medicina
Published: October 11, 2021
Last Updated: 09/26/2026